Veronica Nicole Ortiz, MD
Critical Care (Intensivists) · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 3
Offices
3 locations · University Healthcare Alliance · County of Santa Clara
Looking this up.
Hospitals listed: Good Samaritan Hospital · Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ortiz’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A123496 · Current
Licensed to practise in California · since 2012 · expires 2026-11-30 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$86,784
Medicare paid this office $86,784 for 379 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 91 | $34,089 | $185 |
| Short return visit (20+ min) | 138 | $15,765 | $83 |
| Return visit (30+ min) | 49 | $9,782 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $8,556 | $70 |
| New patient visit (30+ min) | 63 | $6,101 | $97 |
See all 8 services
| Critical care, first 30-74 minutes | 91 | $34,089 | $185 |
| Short return visit (20+ min) | 138 | $15,765 | $83 |
| Return visit (30+ min) | 49 | $9,782 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $8,556 | $70 |
| New patient visit (30+ min) | 63 | $6,101 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,431 | $111 |
| Test to measure expiratory airflow and volume | 63 | $2,209 | $25 |
| New patient visit (45+ min) | 13 | $1,902 | $146 |
Who their Medicare patients are
379 Original Medicare patients in 2024. Average age 77 · Under 65 6% · 85 and older 22% · Women 50% · Also on Medicaid 17% · Health risk score 1.91. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 2.58.
Conditions among them: High blood pressure 75% · Diabetes 45% · Coronary heart disease 40% · Chronic kidney disease 39% · Heart failure 35% · COPD 35% · Atrial fibrillation 34% · Depression 23% · Cancer 17% · Stroke 16% · Dementia 15%.
The office billed $419,270, Medicare allowed $113,941 and paid $86,784; for 842 services of 31 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 379 | 842 | 77 | 1.91 | $419,270 | $86,784 |
| 2023 | 344 | 921 | 77 | 1.87 | $556,228 | $116,298 |
| 2022 | 370 | 1,040 | 77 | 1.76 | $670,810 | $140,910 |
| 2021 | 325 | 654 | 74 | 2.10 | $413,195 | $75,864 |
| 2020 | 334 | 703 | 74 | 2.75 | $673,594 | $87,979 |
| 2019 | 354 | 867 | 76 | 2.77 | $726,529 | $110,172 |
| 2018 | 305 | 852 | 75 | 2.88 | $554,228 | $117,644 |
| 2017 | 362 | 1,193 | 75 | 2.67 | $640,124 | $160,898 |
| 2016 | 234 | 779 | 73 | 2.49 | $396,314 | $100,670 |
| 2015 | 237 | 793 | 73 | 2.62 | $402,642 | $107,779 |
| 2014 | 246 | 716 | 71 | 2.91 | $343,728 | $98,146 |
| 2013 | 81 | 241 | 69 | 2.80 | $96,169 | $30,952 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 9 services
| Critical care, first 30-74 minutes | 138 | $71,825 | $190 |
| Short return visit (20+ min) | 103 | $11,093 | $82 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $8,751 | $109 |
| Return visit (30+ min) | 50 | $8,050 | $117 |
| New patient visit (30+ min) | 42 | $4,256 | $101 |
| New patient visit (45+ min) | 23 | $3,416 | $149 |
| Test to measure expiratory airflow and volume | 65 | $2,214 | $26 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,914 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $1,093 | $73 |
2022: 8 services
| Critical care, first 30-74 minutes | 156 | $94,903 | $194 |
| Return visit (30+ min) | 61 | $12,200 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 39 | $9,740 | $96 |
| Short return visit (20+ min) | 87 | $8,027 | $76 |
| New patient visit (45+ min) | 25 | $3,809 | $152 |
| New patient visit (30+ min) | 35 | $3,461 | $99 |
| Test to measure expiratory airflow and volume | 66 | $2,306 | $25 |
| Telephone medical discussion with physician, 11-20 minutes | 21 | $1,256 | $60 |
2021: 11 services
| Critical care, first 30-74 minutes | 78 | $32,595 | $201 |
| Return visit (30+ min) | 65 | $13,576 | $122 |
| Short return visit (20+ min) | 69 | $7,534 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $5,277 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $4,748 | $106 |
| New patient visit (30+ min) | 26 | $2,757 | $106 |
| New patient visit (45+ min) | 18 | $2,748 | $153 |
| Telephone medical discussion with physician, 11-20 minutes | 19 | $1,995 | $80 |
| Test to measure expiratory airflow and volume | 28 | $981 | $32 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $398 | $27 |
| Test to measure expiratory airflow and volume | 12 | $93 | $8 |
2020: 11 services
| Critical care, first 30-74 minutes | 171 | $56,135 | $208 |
| Return visit (30+ min) | 46 | $7,208 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $6,378 | $75 |
| New patient visit (45+ min) | 22 | $3,131 | $142 |
| Short return visit (20+ min) | 45 | $3,103 | $55 |
| Telephone medical discussion with physician, 11-20 minutes | 28 | $2,607 | $72 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,600 | $94 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $748 | $42 |
| Administration of influenza virus vaccine | 13 | $272 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 13 | $255 | $20 |
| Test to measure expiratory airflow and volume | 11 | $86 | $8 |
2019: 11 services
| Critical care, first 30-74 minutes | 171 | $71,178 | $196 |
| Return visit (30+ min) | 56 | $10,177 | $99 |
| Short return visit (20+ min) | 69 | $7,039 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 43 | $5,668 | $66 |
| New patient visit (45+ min) | 35 | $4,802 | $137 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 32 | $4,145 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,483 | $124 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,270 | $91 |
| Administration of influenza virus vaccine | 16 | $390 | $21 |
| Test to measure expiratory airflow and volume | 22 | $358 | $16 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 16 | $354 | $19 |
2018: 8 services
| Critical care, first 30-74 minutes | 160 | $77,987 | $192 |
| Return visit (30+ min) | 76 | $12,606 | $91 |
| New patient visit (45+ min) | 41 | $5,831 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $5,322 | $92 |
| Short return visit (20+ min) | 50 | $4,350 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,496 | $178 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 14 | $1,895 | $135 |
| Test to measure expiratory airflow and volume | 31 | $1,164 | $36 |
2017: 8 services
| Critical care, first 30-74 minutes | 180 | $108,255 | $184 |
| Return visit (30+ min) | 96 | $17,265 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $12,447 | $88 |
| New patient visit (45+ min) | 63 | $8,511 | $135 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,961 | $165 |
| Short return visit (20+ min) | 39 | $2,652 | $56 |
| Test to measure expiratory airflow and volume | 52 | $1,653 | $32 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 12 | $1,479 | $123 |
2016: 9 services
| Critical care, first 30-74 minutes | 97 | $58,533 | $190 |
| Return visit (30+ min) | 92 | $16,293 | $92 |
| New patient visit (45+ min) | 63 | $8,471 | $134 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $4,336 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,142 | $175 |
| Test to measure expiratory airflow and volume | 52 | $1,812 | $35 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 12 | $1,695 | $141 |
| Short return visit (20+ min) | 12 | $1,009 | $67 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $288 | $18 |
2015: 11 services
| Critical care, first 30-74 minutes | 103 | $58,218 | $195 |
| New patient visit (45+ min) | 74 | $11,805 | $160 |
| Return visit (30+ min) | 59 | $11,690 | $106 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 53 | $8,128 | $86 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,605 | $109 |
| Sleep study including heart rate, breathing, airflow, and effort | 13 | $2,309 | $178 |
| Test to measure expiratory airflow and volume | 52 | $2,126 | $39 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 21 | $1,747 | $83 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 14 | $1,267 | $90 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 12 | $1,197 | $100 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $350 | $21 |
2014: 9 services
| Critical care, first 30-74 minutes | 136 | $59,424 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $12,074 | $84 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 65 | $7,308 | $111 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $4,740 | $163 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 36 | $4,622 | $122 |
| Emergent insertion of breathing tube into windpipe using an endoscope | 37 | $3,380 | $89 |
| Insertion of non-tunneled central venous tube for infusion (5 years or older) | 26 | $2,764 | $99 |
| Diagnostic exam of lung airway using an endoscope | 14 | $1,797 | $120 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $698 | $58 |
2013: 3 services
| Critical care, first 30-74 minutes | 49 | $19,378 | $173 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $5,993 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,538 | $107 |
Medicaid work
$2,015 in 2021
Medicaid paid $2,015 for 58 billed services this clinician did in 2021, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 15 | $1,263 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 43 | $752 |
| 2021 | 58 | 2 | 14 | $2,015 |
| 2020 | 372 | 3 | 27 | $23,424 |
| 2019 | 142 | 1 | 20 | $8,799 |
| 2018 | 180 | 1 | 15 | $9,275 |
See the largest Medicaid services in earlier years
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 308 | $22,302 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 46 | $864 |
| SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES | 18 | $258 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 142 | $8,799 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 180 | $9,275 |
Drugs they prescribed that Part D paid
$769,534
Pharmacies billed $769,534 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,440) in 2024. At or below the middle of the specialty; the typical critical care (intensivists) clinician is at 0%.
556 generic and 884 brand-name prescriptions · $769,534 in drug cost · 38 antibiotic prescriptions to 25 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofev | 26 | $341,080 | $13,118 |
| Trelegy Ellipta | 251 | $186,951 | $745 |
| Anoro Ellipta | 109 | $61,631 | $565 |
| Spiriva Handihaler | 57 | $37,015 | $649 |
| Spiriva Respimat | 32 | $18,180 | $568 |
See all 22 drugs
| Ofev | 26 | $341,080 | $13,118 |
| Trelegy Ellipta | 251 | $186,951 | $745 |
| Anoro Ellipta | 109 | $61,631 | $565 |
| Spiriva Handihaler | 57 | $37,015 | $649 |
| Spiriva Respimat | 32 | $18,180 | $568 |
| Wixela Inhub | 116 | $15,172 | $131 |
| Breo Ellipta | 35 | $15,157 | $433 |
| Combivent Respimat | 12 | $12,228 | $1,019 |
| Fluticasone Propionate Hfa | 36 | $9,596 | $267 |
| Advair Hfa | 21 | $7,707 | $367 |
| Atrovent Hfa | 15 | $7,661 | $511 |
| Albuterol Sulfate Hfa | 245 | $6,555 | $27 |
| Arnuity Ellipta | 19 | $6,506 | $342 |
| Incruse Ellipta | 13 | $6,440 | $495 |
| Fluticasone-Salmeterol | 32 | $4,921 | $154 |
| Symbicort | 14 | $4,409 | $315 |
| Ventolin Hfa | 51 | $2,937 | $58 |
| Montelukast | 95 | $1,096 | $12 |
| Modafinil | 12 | $412 | $34 |
| Prednisone | 74 | $165 | $2 |
| Azithromycin | 20 | $72 | $4 |
| Zolpidem | 13 | $17 | $1 |
Year by year
| 2024 | 1,440 | 241 | 0% (0) | 61% | $769,534 |
| 2023 | 1,488 | 232 | None | 65% | $760,379 |
| 2022 | 1,542 | 221 | None | 65% | $961,385 |
| 2021 | 1,342 | 206 | 0% (0) | 65% | $925,598 |
| 2020 | 1,046 | 148 | None | 60% | $766,420 |
| 2019 | 1,049 | 173 | None | 58% | $673,550 |
| 2018 | 1,280 | 188 | None | 64% | $819,274 |
| 2017 | 1,377 | 205 | None | 57% | $577,505 |
| 2016 | 1,039 | 188 | 0% (0) | 63% | $214,017 |
| 2015 | 383 | 118 | 0% (0) | 66% | $56,209 |
| 2013 | 27 | None | 0% (0) | 81% | $7,193 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Ofev | 19 | $251,839 | $13,255 |
| Trelegy Ellipta | 287 | $220,022 | $767 |
| Anoro Ellipta | 105 | $61,556 | $586 |
| Spiriva Handihaler | 94 | $56,899 | $605 |
| Spiriva Respimat | 46 | $29,955 | $651 |
| Wixela Inhub | 71 | $14,180 | $200 |
| Advair Diskus | 32 | $12,949 | $405 |
| Incruse Ellipta | 30 | $12,612 | $420 |
| Atrovent Hfa | 23 | $11,230 | $488 |
| Flovent Hfa | 24 | $9,450 | $394 |
| Symbicort | 21 | $8,881 | $423 |
| Stiolto Respimat | 17 | $8,706 | $512 |
| Albuterol Sulfate Hfa | 235 | $7,208 | $31 |
| Breo Ellipta | 16 | $6,711 | $419 |
| Fluticasone-Salmeterol | 21 | $6,055 | $288 |
| Advair Hfa | 13 | $5,821 | $448 |
| Montelukast | 111 | $2,375 | $21 |
| Ventolin Hfa | 15 | $1,022 | $68 |
| Pantoprazole | 26 | $555 | $21 |
| Fluticasone Propionate | 20 | $311 | $16 |
| Prednisone | 68 | $229 | $3 |
| Zolpidem | 12 | $141 | $12 |
| Azithromycin | 17 | $119 | $7 |
2022: 28 drugs
| Ofev | 27 | $343,870 | $12,736 |
| Trelegy Ellipta | 257 | $189,884 | $739 |
| Spiriva Handihaler | 129 | $84,968 | $659 |
| Anoro Ellipta | 69 | $38,710 | $561 |
| Spiriva Respimat | 39 | $25,007 | $641 |
| Breo Ellipta | 44 | $21,083 | $479 |
| Stiolto Respimat | 30 | $20,472 | $682 |
| Advair Diskus | 39 | $18,547 | $476 |
| Symbicort | 31 | $17,651 | $569 |
| Incruse Ellipta | 27 | $12,823 | $475 |
| Atrovent Hfa | 18 | $11,573 | $643 |
| Wixela Inhub | 64 | $11,341 | $177 |
| Advair Hfa | 23 | $10,592 | $461 |
| Flovent Hfa | 19 | $8,329 | $438 |
| Albuterol Sulfate Hfa | 201 | $8,272 | $41 |
| Arnuity Ellipta | 11 | $5,925 | $539 |
| Serevent Diskus | 11 | $5,495 | $500 |
| Daliresp | 12 | $5,190 | $432 |
| Montelukast | 107 | $2,608 | $24 |
| Fluticasone-Salmeterol | 12 | $2,225 | $185 |
| Ventolin Hfa | 20 | $1,206 | $60 |
| Fluticasone Propionate | 43 | $678 | $16 |
| Pantoprazole | 26 | $628 | $24 |
| Azithromycin | 24 | $432 | $18 |
| Prednisone | 84 | $342 | $4 |
| Gabapentin | 20 | $151 | $8 |
| Zolpidem | 12 | $101 | $8 |
| Clonazepam | 12 | $98 | $8 |
2021: 29 drugs
| Ofev | 40 | $466,618 | $11,665 |
| Trelegy Ellipta | 112 | $75,953 | $678 |
| Spiriva | 99 | $56,756 | $573 |
| Breo Ellipta | 66 | $26,579 | $403 |
| Anoro Ellipta | 43 | $24,448 | $569 |
| Symbicort | 35 | $21,222 | $606 |
| Stiolto Respimat | 37 | $18,323 | $495 |
| Spiriva Respimat | 29 | $18,295 | $631 |
| Advair Diskus | 29 | $17,043 | $588 |
| Wixela Inhub | 29 | $10,193 | $351 |
| Incruse Ellipta | 20 | $8,637 | $432 |
| Albuterol Sulfate Hfa | 190 | $8,302 | $44 |
| Flovent Hfa | 22 | $7,731 | $351 |
| Daliresp | 15 | $6,677 | $445 |
| Fluticasone-Salmeterol | 29 | $6,133 | $211 |
| Arnuity Ellipta | 16 | $4,703 | $294 |
| Dulera | 13 | $3,558 | $274 |
| Ventolin Hfa | 36 | $2,052 | $57 |
| Proair Hfa | 18 | $1,586 | $88 |
| Montelukast | 102 | $1,515 | $15 |
| Prednisone | 96 | $551 | $6 |
| Ipratropium | 14 | $458 | $33 |
| Pantoprazole | 15 | $440 | $29 |
| Fluticasone Propionate | 19 | $315 | $17 |
| Azithromycin | 24 | $283 | $12 |
| Clonazepam | 15 | $169 | $11 |
| Omeprazole | 11 | $155 | $14 |
| Gabapentin | 15 | $89 | $6 |
| Zolpidem | 12 | $71 | $6 |
2020: 27 drugs
| Ofev | 29 | $315,091 | $10,865 |
| Esbriet | 21 | $194,475 | $9,261 |
| Spiriva | 84 | $53,299 | $635 |
| Anoro Ellipta | 61 | $30,926 | $507 |
| Trelegy Ellipta | 29 | $20,432 | $705 |
| Stiolto Respimat | 37 | $20,008 | $541 |
| Symbicort | 32 | $16,909 | $528 |
| Spiriva Respimat | 22 | $15,133 | $688 |
| Advair Diskus | 17 | $12,643 | $744 |
| Breo Ellipta | 18 | $9,218 | $512 |
| Incruse Ellipta | 19 | $6,937 | $365 |
| Flovent Hfa | 19 | $6,754 | $355 |
| Arnuity Ellipta | 19 | $4,823 | $254 |
| Wixela Inhub | 13 | $4,453 | $343 |
| Proair Hfa | 40 | $4,075 | $102 |
| Fluticasone-Salmeterol | 20 | $3,690 | $184 |
| Albuterol Sulfate Hfa | 76 | $3,665 | $48 |
| Ventolin Hfa | 48 | $2,759 | $57 |
| Montelukast | 100 | $1,748 | $17 |
| Prednisone | 104 | $650 | $6 |
| Fluticasone Propionate | 26 | $499 | $19 |
| Ipratropium | 13 | $274 | $21 |
| Omeprazole | 11 | $233 | $21 |
| Azithromycin | 12 | $166 | $14 |
| Pantoprazole | 19 | $142 | $7 |
| Zolpidem | 13 | $80 | $6 |
| Gabapentin | 15 | $62 | $4 |
2019: 25 drugs
| Ofev | 32 | $334,915 | $10,466 |
| Esbriet | 12 | $91,454 | $7,621 |
| Spiriva | 106 | $65,224 | $615 |
| Anoro Ellipta | 45 | $21,546 | $479 |
| Spiriva Respimat | 27 | $19,486 | $722 |
| Symbicort | 38 | $18,708 | $492 |
| Advair Diskus | 26 | $18,121 | $697 |
| Trelegy Ellipta | 29 | $15,842 | $546 |
| Stiolto Respimat | 21 | $10,195 | $485 |
| Flovent Hfa | 19 | $6,089 | $320 |
| Proair Hfa | 79 | $6,046 | $77 |
| Incruse Ellipta | 12 | $4,805 | $400 |
| Daliresp | 12 | $4,534 | $378 |
| Ventolin Hfa | 71 | $4,113 | $58 |
| Montelukast | 96 | $2,491 | $26 |
| Theophylline Anhydrous | 12 | $1,708 | $142 |
| Pantoprazole | 31 | $821 | $26 |
| Albuterol Sulfate Hfa | 15 | $707 | $47 |
| Azithromycin | 24 | $574 | $24 |
| Fluticasone Propionate | 27 | $544 | $20 |
| Prednisone | 117 | $506 | $4 |
| Omeprazole | 14 | $302 | $22 |
| Levofloxacin | 19 | $262 | $14 |
| Gabapentin | 16 | $124 | $8 |
| Zolpidem | 14 | $82 | $6 |
2018: 24 drugs
| Ofev | 36 | $338,984 | $9,416 |
| Esbriet | 23 | $192,134 | $8,354 |
| Spiriva | 236 | $120,398 | $510 |
| Advair Diskus | 59 | $35,130 | $595 |
| Anoro Ellipta | 47 | $21,382 | $455 |
| Symbicort | 30 | $14,896 | $497 |
| Stiolto Respimat | 37 | $13,907 | $376 |
| Spiriva Respimat | 20 | $11,444 | $572 |
| Breo Ellipta | 21 | $9,723 | $463 |
| Proair Hfa | 120 | $8,730 | $73 |
| Dulera | 18 | $6,687 | $371 |
| Flovent Hfa | 23 | $6,148 | $267 |
| Ventolin Hfa | 80 | $4,687 | $59 |
| Montelukast | 143 | $3,400 | $24 |
| Arnuity Ellipta | 11 | $2,516 | $229 |
| Theophylline Anhydrous | 12 | $1,494 | $125 |
| Fluticasone Propionate | 22 | $705 | $32 |
| Prednisone | 115 | $622 | $5 |
| Omeprazole | 16 | $447 | $28 |
| Pantoprazole | 22 | $440 | $20 |
| Azithromycin | 25 | $320 | $13 |
| Levofloxacin | 22 | $251 | $11 |
| Clonazepam | 12 | $82 | $7 |
| Zolpidem | 13 | $78 | $6 |
2017: 26 drugs
| Ofev | 20 | $173,502 | $8,675 |
| Esbriet | 22 | $166,994 | $7,591 |
| Spiriva | 210 | $93,128 | $443 |
| Advair Diskus | 95 | $39,206 | $413 |
| Symbicort | 50 | $19,247 | $385 |
| Proair Hfa | 147 | $9,231 | $63 |
| Advair Hfa | 15 | $7,712 | $514 |
| Flovent Hfa | 28 | $7,558 | $270 |
| Spiriva Respimat | 16 | $7,369 | $461 |
| Combivent Respimat | 20 | $6,947 | $347 |
| Stiolto Respimat | 14 | $4,817 | $344 |
| Chantix | 13 | $4,735 | $364 |
| Dulera | 13 | $3,869 | $298 |
| Ventolin Hfa | 46 | $2,828 | $61 |
| Montelukast | 186 | $2,409 | $13 |
| Arnuity Ellipta | 11 | $2,377 | $216 |
| Fluticasone Propionate | 51 | $639 | $13 |
| Prednisone | 114 | $602 | $5 |
| Omeprazole | 23 | $562 | $24 |
| Pantoprazole | 41 | $387 | $9 |
| Zolpidem | 17 | $201 | $12 |
| Doxycycline Hyclate | 12 | $177 | $15 |
| Levofloxacin | 19 | $119 | $6 |
| Azithromycin | 16 | $117 | $7 |
| Isoniazid | 13 | $83 | $6 |
| Clonazepam | 15 | $67 | $4 |
2016: 19 drugs
| Spiriva | 118 | $44,904 | $381 |
| Advair Diskus | 79 | $27,489 | $348 |
| Symbicort | 59 | $17,203 | $292 |
| Flovent Hfa | 64 | $16,091 | $251 |
| Proair Hfa | 168 | $9,284 | $55 |
| Advair Hfa | 17 | $5,685 | $334 |
| Tudorza Pressair | 18 | $3,884 | $216 |
| Combivent Respimat | 11 | $3,438 | $313 |
| Qvar | 12 | $2,788 | $232 |
| Pulmicort Flexhaler | 16 | $2,557 | $160 |
| Montelukast | 126 | $1,709 | $14 |
| Ventolin Hfa | 22 | $1,206 | $55 |
| Fluticasone Propionate | 43 | $754 | $18 |
| Omeprazole | 23 | $522 | $23 |
| Prednisone | 77 | $437 | $6 |
| Pantoprazole | 31 | $316 | $10 |
| Levofloxacin | 16 | $193 | $12 |
| Azithromycin | 19 | $145 | $8 |
| Zolpidem | 13 | $49 | $4 |
2015: 10 drugs
| Spiriva | 39 | $14,886 | $382 |
| Advair Diskus | 38 | $11,844 | $312 |
| Flovent Hfa | 18 | $5,131 | $285 |
| Qvar | 24 | $4,543 | $189 |
| Proair Hfa | 65 | $3,358 | $52 |
| Ventolin Hfa | 22 | $1,145 | $52 |
| Fluticasone Propionate | 21 | $334 | $16 |
| Prednisone | 33 | $186 | $6 |
| Montelukast | 14 | $163 | $12 |
| Zolpidem | 11 | $59 | $5 |
2013: 1 drug
| Advair Diskus | 12 | $5,908 | $492 |
Money from drug and device companies
$15 in 2025
| 2025 | 1 | 1 | None | $15 |
| 2024 | 3 | 6 | None | $186 |
| 2023 | 2 | 3 | None | $66 |
| 2022 | 1 | 4 | None | $89 |
| 2021 | 3 | 4 | None | $77 |
| 2020 | 2 | 2 | None | $25 |
| 2019 | 3 | 7 | None | $87 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Viatris Specialty | Yupelri | $15 | 1 payment
|
See the published payment
| Viatris Specialty | Meals · 2025-01-17 | Yupelri | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $186
| AstraZeneca Pharmaceuticals LP | Airsupra | $137 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $32 | 2 payments
|
| Insmed | Arikayce | $16 | 1 payment
|
2023: $66
| Mylan Specialty L.P. | Yupelri | $41 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $26 | 1 payment
|
2022: $89
| GlaxoSmithKline | Trelegy Ellipta | $89 | 4 payments
|
2021: $77
| Boehringer Ingelheim Pharmaceuticals | Ofev | $46 | 2 payments
|
| Genentech USA | Esbriet | $19 | 1 payment
|
| Philips Electronics North America | (9369) Reusable Vest | $13 | 1 payment
|
2020: $25
| Sunovion Pharmaceuticals | Lonhala Magnair | $14 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $11 | 1 payment
|
2019: $87
| Genentech USA | Esbriet | $41 | 2 payments
|
| Sunovion Pharmaceuticals | Lonhala Magnair | $27 | 4 payments
|
| Mylan Specialty L.P. | Yupelri | $19 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1851592844
- Licence
- CA A123496California A123496: Current · expires 2026-11-30
- Group
- University Healthcare Alliance · County of Santa Clara
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RC0200X (207RC0200X); Federal specialty code 207RP1001X (207RP1001X)
- Mailing address
- 2425 Samaritan Dr, San Jose, CA, 95124
- NPI first listed
- 2007-05-29
- NPI last updated
- 2023-09-26
- NPI record certified
- 2023-09-26
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 227 N Jackson Ave, San Jose, CA, 95116